Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-23

FDA Approved: NAMZARIC — Original Application (Allergan, Inc.)

View source ↗

Summary

FDA approved NAMZARIC, a fixed-dose combination of memantine hydrochloride and donepezil hydrochloride, under an original application from Allergan for the trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAMZARIC (Memantine hydrochloride and donepezil hydrochloride)

Snippet

ORIG AP for NAMZARIC (MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE)